메뉴 건너뛰기




Volumn 10, Issue 4 PART 3, 2009, Pages 919-924

Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug

Author keywords

Clozapine; Extrapyramidal symptoms rating scale; Schizophrenia; Tardive dyskinesia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; REACTIVE OXYGEN METABOLITE;

EID: 77949525751     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970802481895     Document Type: Article
Times cited : (43)

References (37)
  • 1
    • 0036739725 scopus 로고    scopus 로고
    • A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: The Ziprasidone Extended Use on Schizophrenia (ZEUS) Study
    • Arato M, O'Connor R, Meltzer HY. 2002. A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use on Schizophrenia (ZEUS) Study. Int Clin Psychopharmacol 17:207-215.
    • (2002) Int Clin Psychopharmacol , vol.17 , pp. 207-215
    • Arato, M.1    O'Connor, R.2    Meltzer, H.Y.3
  • 2
    • 2342451962 scopus 로고    scopus 로고
    • Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus
    • Bai O, Zhang H, Li XM. 2004. Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 1010:81-86.
    • (2004) Brain Res , vol.1010 , pp. 81-86
    • Bai, O.1    Zhang, H.2    Li, X.M.3
  • 3
    • 0018756814 scopus 로고
    • The trial use of clozapine for abnormal involuntary movement disorders
    • Caine ED, Polinsky RJ, Kartzinel R, Ebert MH. 1979. The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiatry 136:317-320
    • (1979) Am J Psychiatry , vol.136 , pp. 317-320
    • Caine, E.D.1    Polinsky, R.J.2    Kartzinel, R.3    Ebert, M.H.4
  • 5
    • 0036379097 scopus 로고    scopus 로고
    • Chinese classification of mental disorders (CCMD-3): Towards integration in international classification
    • Chen YF. 2002. Chinese classification of mental disorders (CCMD-3): towards integration in international classification. Psychopathology 35:171-175.
    • (2002) Psychopathology , vol.35 , pp. 171-175
    • Chen, Y.F.1
  • 6
    • 1542373740 scopus 로고    scopus 로고
    • Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies
    • Correll CU, Leucht S, Kane JM. 2004. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161: 414-425
    • (2004) Am J Psychiatry , vol.161 , pp. 414-425
    • Correll, C.U.1    Leucht, S.2    Kane, J.M.3
  • 7
    • 0028200350 scopus 로고
    • Clozapine-related tardive dyskinesia
    • Dave M. 1994. Clozapine-related tardive dyskinesia. Biol Psychiatry 35:886-887.
    • (1994) Biol Psychiatry , vol.35 , pp. 886-887
    • Dave, M.1
  • 8
    • 0026346053 scopus 로고
    • Clozapine and jaw dyskinesia: A case report
    • de Leon J, Moral L, Camunas C. 1991. Clozapine and jaw dyskinesia: a case report. J Clin Psychiatry 52:494-495.
    • (1991) J Clin Psychiatry , vol.52 , pp. 494-495
    • De Leon, J.1    Moral, L.2    Camunas, C.3
  • 9
    • 0016711577 scopus 로고
    • Extrapyramidal symptoms following clozapine therapy: Case report
    • Doepp S, Buddeberg C. 1975. Extrapyramidal symptoms following clozapine therapy: case report. Nervenarzt 46:589-590.
    • (1975) Nervenarzt , vol.46 , pp. 589-590
    • Doepp, S.1    Buddeberg, C.2
  • 11
    • 25444451402 scopus 로고    scopus 로고
    • Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients
    • Fehsel K, Loeffler S, Krieger K, Henning U, Agelink M, Kolb-Bachofen V, et al. 2005. Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients. J Clin Psychopharmacol 25:419-426
    • (2005) J Clin Psychopharmacol , vol.25 , pp. 419-426
    • Fehsel, K.1    Loeffler, S.2    Krieger, K.3    Henning, U.4    Agelink, M.5    Kolb-Bachofen, V.6
  • 12
    • 0034116158 scopus 로고    scopus 로고
    • Prevalence of spontaneous dyskinesia in schizophrenia
    • Fenton WS. 2000. Prevalence of spontaneous dyskinesia in schizophrenia. J Clin Psychiatry 61:10-14.
    • (2000) J Clin Psychiatry , vol.61 , pp. 10-14
    • Fenton, W.S.1
  • 13
    • 0042973812 scopus 로고    scopus 로고
    • Three case reports of emergent dyskinesia with clozapine
    • Gafoor R, Brophy J. 2003. Three case reports of emergent dyskinesia with clozapine. Eur Psychiatry 18:260-261.
    • (2003) Eur Psychiatry , vol.18 , pp. 260-261
    • Gafoor, R.1    Brophy, J.2
  • 16
    • 0023783650 scopus 로고
    • Tardive dyskinesia: Prevalence, incidence and risk factors
    • Kane JM, Woerner M, Lieberman J. 1988. Tardive dyskinesia: prevalence, incidence and risk factors. J Clin Psychopharmacol 8:52-56.
    • (1988) J Clin Psychopharmacol , vol.8 , pp. 52-56
    • Kane, J.M.1    Woerner, M.2    Lieberman, J.3
  • 18
    • 0033994522 scopus 로고    scopus 로고
    • Tardive dyskinesia is associated with impaired retrieval from long-term memory: The Curacao Extrapyramidal Syndrome Study IV
    • Krabbendam L, van Harten PN, Picus I, Jolles J. 2000. Tardive dyskinesia is associated with impaired retrieval from long-term memory: the Curacao Extrapyramidal Syndrome Study IV. Schizophr Res 42:41-46
    • (2000) Schizophr Res , vol.42 , pp. 41-46
    • Krabbendam, L.1    Van Harten, P.N.2    Picus, I.3    Jolles, J.4
  • 19
    • 0030612278 scopus 로고    scopus 로고
    • Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: Effects of chronic treatment with typical and atypical antipsychotic drugs
    • Lidow MS, Goldman-Rakic PS. 1997. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. J Pharmacol Exp Ther 283:939-946.
    • (1997) J Pharmacol Exp Ther , vol.283 , pp. 939-946
    • Lidow, M.S.1    Goldman-Rakic, P.S.2
  • 22
    • 33745309324 scopus 로고    scopus 로고
    • Aripiprazole-related tardive dyskinesia
    • Maytal G, Ostacher M, Stern TA. 2006. Aripiprazole-related tardive dyskinesia. CNS Spectr 11:435-439.
    • (2006) CNS Spectr , vol.11 , pp. 435-439
    • Maytal, G.1    Ostacher, M.2    Stern, T.A.3
  • 23
    • 0021645775 scopus 로고
    • Effect of clozapine in severe tardive dyskinesia: A case report
    • Meltzer HY, Luchins DJ. 1984. Effect of clozapine in severe tardive dyskinesia: a case report. J Clin Psychopharmacol 4: 286-287.
    • (1984) J Clin Psychopharmacol , vol.4 , pp. 286-287
    • Meltzer, H.Y.1    Luchins, D.J.2
  • 24
    • 0032977410 scopus 로고    scopus 로고
    • The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
    • Meltzer HY, McGurk SR. 1999. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233-255.
    • (1999) Schizophr Bull , vol.25 , pp. 233-255
    • Meltzer, H.Y.1    McGurk, S.R.2
  • 26
    • 27744435853 scopus 로고    scopus 로고
    • Clinical correlates of tardive dyskinesia in schizophrenia: Baseline data from the CATIE schizophrenia trial
    • Miller DD, McEvoy JP, Davis SM, Caroff SN, Saltz BL, Chakos MH, et al. 2005. Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. Schizophr Res 80:33-43
    • (2005) Schizophr Res , vol.80 , pp. 33-43
    • Miller, D.D.1    McEvoy, J.P.2    Davis, S.M.3    Caroff, S.N.4    Saltz, B.L.5    Chakos, M.H.6
  • 27
    • 0025239750 scopus 로고
    • Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study
    • Moghaddam B, Bunney BS. 1990. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 54:1755-1760.
    • (1990) J Neurochem , vol.54 , pp. 1755-1760
    • Moghaddam, B.1    Bunney, B.S.2
  • 28
    • 0025167982 scopus 로고
    • Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain
    • O'Dell SJ, La Hoste GJ, Widmark CB, Shapiro RM, Potkin SG, Marshall JF. 1990. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse 6:146-153.
    • (1990) Synapse , vol.6 , pp. 146-153
    • O'Dell, S.J.1    La Hoste, G.J.2    Widmark, C.B.3    Shapiro, R.M.4    Potkin, S.G.5    Marshall, J.F.6
  • 29
    • 0029938033 scopus 로고    scopus 로고
    • Clozapine versus typical antipsychotics: A retro-and prospective study of extrapyramidal side effects
    • Peacock L, Solgaard T, Lublin H, Gerlach J. 1996. Clozapine versus typical antipsychotics: a retro-and prospective study of extrapyramidal side effects. Psychopharmacology 124: 188-196.
    • (1996) Psychopharmacology , vol.124 , pp. 188-196
    • Peacock, L.1    Solgaard, T.2    Lublin, H.3    Gerlach, J.4
  • 30
    • 0038018122 scopus 로고    scopus 로고
    • The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis
    • Qing H, Xu H, Wei Z, Gibson K, Li XM. 2003. The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis. Eur J Neurosci 17: 1563-1570.
    • (2003) Eur J Neurosci , vol.17 , pp. 1563-1570
    • Qing, H.1    Xu, H.2    Wei, Z.3    Gibson, K.4    Li, X.M.5
  • 31
    • 0032935962 scopus 로고    scopus 로고
    • Receptor pharmacology of neuroleptics: Relation to clinical effects
    • Richelson E. 1999. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 60:5-14.
    • (1999) J Clin Psychiatry , vol.60 , pp. 5-14
    • Richelson, E.1
  • 33
    • 0027665283 scopus 로고
    • Cognitive dysfunction in schizophrenia: Organic vulnerability factor or state marker for tardive dyskinesia?
    • Waddington JL, O'Callaghan E, Larkin C, Kinsella A. 1993. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia? Brain Cogn 23:56-70.
    • (1993) Brain Cogn , vol.23 , pp. 56-70
    • Waddington, J.L.1    O'Callaghan, E.2    Larkin, C.3    Kinsella, A.4
  • 36
    • 0026666282 scopus 로고
    • Gender differences in tardive dyskinesia: A critical review of the literature
    • Yassa R, Jeste DV. 1992. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 18:701-715.
    • (1992) Schizophr Bull , vol.18 , pp. 701-715
    • Yassa, R.1    Jeste, D.V.2
  • 37
    • 77951673709 scopus 로고    scopus 로고
    • Prevalence of tarcive dyskinesia in inpatients using antipsycotics
    • Yoon JY, Oh DY, Choi JH. 2004. Prevalence of tarcive dyskinesia in inpatients using antipsycotics. Korean J Psychopharmacol 15:305-311.
    • (2004) Korean J Psychopharmacol , vol.15 , pp. 305-311
    • Yoon, J.Y.1    Oh, D.Y.2    Choi, J.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.